Croaking

$CING - Low Float - Positive Top Line Results - ADHD 1 PILL

看多
Croaking 已更新   
NASDAQ:CING   Cingulate Inc.
We are traveling the bottom of the channel. I think it starts to move up shortly. Adolescent and Pediatric fixed dose phase 3 trials start this month and next month. FDA approval submission early/mid next year. Billion-dollar drug if it can get some funding? This is my own opinion, and you should not take any of this as financial advice.
評論:
Curious what this would mean for the current producers of such meds like JNJ , PFE , NVS ? I'm assuming they would buy out Cingulate quickly before something like that dented their sales.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。